Registration of patients with thyroid cancer
Official title: Descriptive Observational Epidemiological Study on the Characteristics of Thyroid Cancer in Patients Treated in Oncology Services of Spanish Centers: National Registry of Thyroid Cancer - Differentiated, Medullary and Anaplastic
Run by Grupo Espanol de Tumores Neuroendocrinos · NCT03765333 · Data updated 2026-11-12
This study is collecting information on adults with different types of thyroid cancer to better understand their experiences and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Grupo Espanol de Tumores Neuroendocrinos Academic / other |
| Locations | 1 site (Barcelona, Barcelona) |
| Status | Recruiting |
| Started | May 28, 2019 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT03765333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a confirmed diagnosis of differentiated, medullary, or anaplastic thyroid cancer.
✕Probably not a fit
Patients under 18 years of age or those with unconfirmed or different types of thyroid cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect epidemiological data on patients aged 18 and older who have been diagnosed with primary thyroid cancer. It will involve multiple centers and will focus on patients with differentiated, medullary, or anaplastic thyroid cancer confirmed by histopathology. The study will gather retrospective data from oncology services to better understand the characteristics and outcomes of these patients.
Why it matters
Potential benefit: If successful, this study could enhance understanding of thyroid cancer and improve patient management strategies.
How similar studies have gone: Other observational studies in oncology have shown success in collecting valuable data, making this approach well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology. * Patients who agree to participate and are able to understand the information sheet and sign the informed consent Exclusion Criteria: * Patients under 18 years of age. * Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed. * Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.
Where it's running
-
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Secretaria Técnica GETNE
- Email: getne@mfar.net
- Phone: +34 93 434 44 12
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MRG003 added to ongoing treatment after progression in EGFR-positive advanced thyroid cancer
In this study, researchers test whether adding MRG003 to a patient’s current thyroid cancer treatment can shrink tumors for those whose cancer initially responded but later progressed.
-
Selective coverage radiotherapy vs. full coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer
This trial tests whether covering only the tumor-affected area with radiation is as effective as full-area coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer, while aiming to reduce side effects and improve quality of life.
-
Trop-2 Targeted PET/CT for Recurrent and Metastatic Thyroid Cancer
This study tests whether a Trop-2 targeted PET/CT scan can better detect recurrent or metastatic thyroid cancer in adults than another PET/CT scan (FAPI).
-
WeChat-supported neck exercises after thyroidectomy
A telehealth program using a WeChat mini program tests if guided neck exercises after thyroid surgery help early recovery and quality of life.
-
Pralsetinib Drug Interaction Study in RET Fusion/MUTATION Positive Solid Tumors
This trial tests whether pralsetinib changes how the body processes certain medicines in adults with RET fusion- or mutation-positive advanced solid tumors.
-
AI chatbot to guide thyroid cancer patients through perioperative education
A new AI chatbot is being tested to see if it helps thyroid cancer patients better prepare for discharge, recover well, and stay engaged in their care compared with traditional education.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.